Australia
Clinical stage cannabinoid company Botanix Pharmaceuticals Limited is pleased to announce new data from studies recently conducted with its antimicrobial product BTX 1801.
Regenerative medicine company Orthocell Limited is pleased to announce all patients have successfully completed the CelGro® single-stage dental implant study designed to assess effectiveness and predictability in accelerating treatment timeframes.
Australian medicinal cannabis company Althea Group Holdings Limited is pleased to provide the following update regarding the uptake of its medicinal cannabis products in Australia.
Novotech, the Asia-Pacific CRO, has again won the prestigious Asia-Pacific CRO of the year awarded by leading analyst firm Frost & Sullivan.
Regenerative medicine company Orthocell Limited is pleased to announce that it has received firm commitments for a A$10.6m placement (“Placement”) from professional and sophisticated investors, including existing shareholders providing $10m net of expenses.
Australian researchers have used a unique combination of cutting-edge technologies to discover a biochemical mechanism fundamental to life.
Sorilux was approved for the treatment of patients age 12 and up.
There are plenty of great scientific research stories out this week. Here’s a look at just a few of them.
Pharma and biotech companies from across the globe provide business and pipeline updates, with news from Gecko, ValGenesis, NeuClone, Zymeworks, and more.
The Global Health Investment Fund (GHIF) and Medicines Development for Global Health (MDGH) announced the sale of MDGH’s Priority Review Voucher (PRV).
PRESS RELEASES